Oncology

GlaxoSmithKline is introducing Tykerb, a dual kinase inhibitor that inhibits breast cancer cell growth.

Head of Novartis Oncology gives an insider view on drug development; warns that as therapies help cancer patients live longer, long-term care will fall to family physicians

.

Hoffmann-La Roche's Avastin (bevacizumab for injection) is now indicated for the first-line treatment of patients with unresectable advanced, metastatic or recurrent non-squamous non-small cell lung cancer, when used in combination with carboplatin and paclitaxel.

May explain high rates of breast cancer among obese women